EPHA2 antibodies
US12162945B2 · kind B2 · utility
0Cited by
7References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 2022 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | Mar 4, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are EphA2 antibodies. These EphA2 antibodies bind preferentially to tumor tissue than normal tissue and bind to EphA2. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.